Efficacy and safety of efalizumab therapy in two pediatric patients with plaque psoriasis

被引：0
|
作者：
Turner, J [1 ]
机构：
[1] Mid S Dermatol & Skin Canc Ctr, Bartlett, TN USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P183 / P183
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of efalizumab therapy for elderly patients with moderate to severe chronic plaque psoriasis
    Gottlieb, A
    Lizzul, P
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P194 - P194
  • [2] Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis
    Menter, A
    Gordon, K
    Carey, W
    Hamilton, T
    Glazer, S
    Caro, I
    Li, N
    Gulliver, W
    ARCHIVES OF DERMATOLOGY, 2005, 141 (01) : 31 - 38
  • [3] Efalizumab therapy in plaque psoriasis
    Christopher T. Ritchlin
    Current Rheumatology Reports, 2004, 6 (4) : 289 - 290
  • [4] Efficacy and safety of efalizumab therapy in high-need psoriasis patients
    Papp, K
    Langley, R
    Shear, N
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P183 - P183
  • [5] Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis
    Leonardi, C
    Goffe, B
    Sobell, J
    Caro, I
    Wang, X
    Papp, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A58 - A58
  • [6] Safety and tolerability of extended efalizumab therapy in patients with chronic moderate to severe plaque psoriasis
    Gottlieb, A
    Hamilton, T
    Rafal, E
    Caro, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB11 - AB11
  • [7] Efficacy and safety outcomes of long-term efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: an update
    Gottlieb, AB
    Hamilton, T
    Caro, I
    Gordon, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A57 - A57
  • [8] Maintenance of efficacy and safety with continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: Final phase IIIb study results
    Gottlieb, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P1 - P1
  • [9] Efficacy and safety of adalimumab, efalizumab and etanercept in the treatment of plaque-psoriasis 'in daily practice'
    Richter, L.
    Marker, M.
    Monshi, B.
    Mueksch, S. Richter
    Rappersberger, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 25 - 25
  • [10] Efficacy and Safety of Ixekizumab in Pediatric Patients with Moderate-to-Severe Plaque Psoriasis
    Paller, Amy
    Seyger, Marieke
    Alejandro Magarinos, Gabriel
    Bagel, Jerry
    Keller, Stuart
    Capriles, Claudia Rodriguez
    Gallo, Gaia
    Edson-Heredia, Emily
    Li, Lingnan
    Xu, Wen
    Papp, Kim
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 17 - 17
12345